To study the efficacy of Gum Arabic as an immuno modulator and anti-inflammatory agent among COVID 19 seropositive patients..Half of participants will receive Gum Arabic and the other half will receive placebo
Randomized placebo controlled trial including COVID 19 seropositive patients will be treated
with 30 gram per day for 4 weeks, compared to placebo group treated for the same duration in
positive COVID 19 patients.
Blood samples will be taken first at base line level, after two weeks and after the
intervention after satisfying the inclusion and exclusion criteria. The main objective is to
assess the effect of Gum Arabic (acacia Senegal) on immune system among COVID-19 patients.
The outcome of this project understand SARS-CoV-2 immune response in COVID patients and the
effect of Gum Arabic (Acacia Senegal) consumption to counteract progression of the disease
Dietary Supplement: Acacia Senegal
Oral Digestion of Gum Arabic to be consumed early morning on daily basis for 4weeks
Other Name: Gum Arabic
Dietary Supplement: Pectin
Oral Digestion of Pectin to be consumed early morning on daily basis for 12 weeks
Inclusion Criteria:
- COVID 19 infected as proved by real time PCR (polymerase chain reaction) .( newly
diagnosed)
Exclusion Criteria:
- Intubated patients on parental treatment
Omdurman Teaching Hospital
Khartoum, Omdurman, Sudan
Jabra Hospital,
Khartoum, Sudan
Dr Babiker, PhD
+249912951517
rashat33@yahoo.com
Shahenaz Satti, MSc
+249912204825
shahenazsatti@gmail.com